NOVARTIS
LIVE

Serial Number

98308022

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Dec 11, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NOVARTIS Trademark

Serial Number: 98308022

NOVARTIS is a trademark filed by Novartis AG on December 11, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment). The application is currently pending registration.

Owner Contact Info

Novartis AG (13 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

December 11, 2023

Registration Date

Not Registered

Published for Opposition

May 14, 2024

Goods & Services

Downloadable software for the facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields; downloadable software in the nature of a mobile application for facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields

Medical apparatus and instruments for diagnosing and treating cardiovascular diseases; Medical apparatus and instruments for diagnosing and treating dermatological diseases; medical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical apparatus and instruments for diagnosing and treating central nervous system diseases; medical apparatus and instruments for the diagnosis and treatment of gastro-intestinal diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; medical apparatus and instruments for the diagnosis, prevention and treatment of haematology diseases and disorders; medical apparatus and instruments for use in tissue and organ transplantation surgery; medical apparatus and instruments for the diagnosis, prevention and treatment of eye diseases and conditions; medical apparatus and instruments for the diagnosis, prevention and treatment of heart rhythm disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of immune system related diseases and disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of kidney diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of diabetes; medical apparatus and instruments for the diagnosis, prevention and treatment of hypertension; medical apparatus and instruments for the diagnosis, prevention and treatment of skin disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of urinary diseases and disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of ophthalmological diseases and disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of cancer and tumors; medical apparatus and instruments for the diagnosis, prevention and treatment of allergies; medical apparatus and instruments for the diagnosis, prevention and treatment of bone diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of respiratory diseases and asthma; radiological apparatus and instruments for medical use; genetic testing apparatus and instruments for medical use; electromagnetic drug delivery apparatus and instruments for medical use; medical apparatus and instruments for diagnostic radiopharmaceutical use; medical apparatus and instruments for facilitating the inhalation of pharmaceutical preparations; apparatus and instruments for DNA and RNA testing for medical use; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments for introducing pharmaceutical preparations into the human body

Providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields

Filing History

SOU EXTENSION 4 GRANTED
Jul 7, 2026 EX4G
SOU TEAS EXTENSION RECEIVED
Jul 7, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 8, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jan 7, 2026 EX3G
SOU TEAS EXTENSION RECEIVED
Jan 6, 2026 EEXT
SOU EXTENSION 4 FILED
Jan 5, 2026 EXT4
SOU EXTENSION 3 FILED
Jan 5, 2026 EXT3
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 1, 2026 EXRA
CORRECTED NOA E-MAILED
Dec 31, 2025 NOAC
SOU EXTENSION 2 GRANTED
Dec 31, 2025 EX2G
DIVISIONAL PROCESSING COMPLETE
Dec 31, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 30, 2025 AITU
DIVISIONAL REQUEST RECEIVED
Jul 1, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jul 1, 2025 ERTD
SOU TEAS EXTENSION RECEIVED
Jul 1, 2025 EEXT
SOU EXTENSION 2 FILED
Jun 30, 2025 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 7, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 7, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 7, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 7, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 9, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 14, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 14, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 9, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 9, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 9, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 9, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 9, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 8, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 20, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 12, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 12, 2024 NWOS
NEW APPLICATION ENTERED
Dec 11, 2023 NWAP